.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Harvard Business School
Daiichi Sankyo
Colorcon
Merck
McKinsey
Baxter
Chinese Patent Office
QuintilesIMS

Generated: July 23, 2017

DrugPatentWatch Database Preview

Mallinckrodt Ip Company Profile

« Back to Dashboard

What is the competitive landscape for MALLINCKRODT IP, and what generic alternatives to MALLINCKRODT IP drugs are available?

MALLINCKRODT IP has one approved drug.

There are four US patents protecting MALLINCKRODT IP drugs.

There are forty-nine patent family members on MALLINCKRODT IP drugs in twenty-six countries.

Summary for Applicant: Mallinckrodt Ip

Patents:4
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt Ip
OFIRMEV
acetaminophen
SOLUTION;IV (INFUSION)022450-001Nov 2, 2010APRXYesYes► Subscribe► Subscribe
Mallinckrodt Ip
OFIRMEV
acetaminophen
SOLUTION;IV (INFUSION)022450-001Nov 2, 2010APRXYesYes9,399,012*PED► SubscribeY► Subscribe
Mallinckrodt Ip
OFIRMEV
acetaminophen
SOLUTION;IV (INFUSION)022450-001Nov 2, 2010APRXYesYes6,028,222*PED► SubscribeY► Subscribe
Mallinckrodt Ip
OFIRMEV
acetaminophen
SOLUTION;IV (INFUSION)022450-001Nov 2, 2010APRXYesYes6,992,218*PED► SubscribeY► Subscribe
Mallinckrodt Ip
OFIRMEV
acetaminophen
SOLUTION;IV (INFUSION)022450-001Nov 2, 2010APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MALLINCKRODT IP drugs

Drugname Dosage Strength Tradename Submissiondate
acetaminophen
Injection1000 mg/100 mL (10 mg/mL)
OFIRMEV
4/7/2011

International Patent Family for Mallinckrodt Ip Drugs

Country Document Number Estimated Expiration
Russian Federation2192249► Subscribe
Japan2010163462► Subscribe
China1556694► Subscribe
African Regional IP Organization (ARIPO)9801223► Subscribe
MexicoPA03000001► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKesson
McKinsey
Citi
Covington
US Department of Justice
Harvard Business School
Farmers Insurance
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot